101 related articles for article (PubMed ID: 8216332)
21. The E1A oncogene induces resistance to the effects of 1,25-dihydroxyvitamin D3 on inhibition of growth of mouse keratinocytes.
Park K; Bae H; Heydemann A; Roberts AB; Dotto GP; Sporn MB; Kim SJ
Cancer Res; 1994 Dec; 54(23):6087-9. PubMed ID: 7954451
[TBL] [Abstract][Full Text] [Related]
22. The retinoblastoma protein-associated cell cycle arrest in S-phase under moderate hypoxia is disrupted in cells expressing HPV18 E7 oncoprotein.
Amellem O; Sandvik JA; Stokke T; Pettersen EO
Br J Cancer; 1998 Mar; 77(6):862-72. PubMed ID: 9528826
[TBL] [Abstract][Full Text] [Related]
23. 1 alpha,25-dihydroxyvitamin D3 inhibits normal human keratinocyte growth by increasing transforming growth factor beta 2 release.
Haugen JD; Pittelkow MR; Zinsmeister AR; Kumar R
Biochem Biophys Res Commun; 1996 Dec; 229(2):618-23. PubMed ID: 8954947
[TBL] [Abstract][Full Text] [Related]
24. Phosphorylation of retinoblastoma protein assayed in individual HL-60 cells during their proliferation and differentiation.
Juan G; Li X; Darzynkiewicz Z
Exp Cell Res; 1998 Oct; 244(1):83-92. PubMed ID: 9770352
[TBL] [Abstract][Full Text] [Related]
25. Differential effects of 1,25-dihydroxyvitamin D3 and tetradecanoylphorbol acetate on cell cycle and apoptosis of MCF-7 cells and a vitamin D3-resistant variant.
Narvaez CJ; Welsh J
Endocrinology; 1997 Nov; 138(11):4690-8. PubMed ID: 9348195
[TBL] [Abstract][Full Text] [Related]
26. Protein phosphatase type 1-dependent dephosphorylation of the retinoblastoma tumor suppressor protein in ultraviolet-irradiated human skin and keratinocytes.
Edwards MJ; Thomas RC
J Invest Dermatol; 2000 Jul; 115(1):88-94. PubMed ID: 10886513
[TBL] [Abstract][Full Text] [Related]
27. Association of protein phosphatase-1delta with the retinoblastoma protein and reversible phosphatase activation in mitotic HeLa cells and in cells released from mitosis.
Puntoni F; Villa-Moruzzi E
Biochem Biophys Res Commun; 1997 Jun; 235(3):704-8. PubMed ID: 9207224
[TBL] [Abstract][Full Text] [Related]
28. PPAR gamma is an important transcription factor in 1 alpha,25-dihydroxyvitamin D3-induced involucrin expression.
Dai X; Sayama K; Shirakata Y; Tokumaru S; Yang L; Tohyama M; Hirakawa S; Hanakawa Y; Hashimoto K
J Dermatol Sci; 2008 Apr; 50(1):53-60. PubMed ID: 18077140
[TBL] [Abstract][Full Text] [Related]
29. 1,25-Dihydroxy-vitamin-D3 enhances antiproliferative effect and transcription of TGF-beta1 on human keratinocytes in culture.
Kim HJ; Abdelkader N; Katz M; McLane JA
J Cell Physiol; 1992 Jun; 151(3):579-87. PubMed ID: 1295905
[TBL] [Abstract][Full Text] [Related]
30. Regulation of gene Expression by 1alpha,25-dihydroxyvitamin D3 and Its analog EB1089 under growth-inhibitory conditions in squamous carcinoma Cells.
Akutsu N; Lin R; Bastien Y; Bestawros A; Enepekides DJ; Black MJ; White JH
Mol Endocrinol; 2001 Jul; 15(7):1127-39. PubMed ID: 11435613
[TBL] [Abstract][Full Text] [Related]
31. Cell-cycle-dependent changes in ceramide levels preceding retinoblastoma protein dephosphorylation in G2/M.
Lee JY; Leonhardt LG; Obeid LM
Biochem J; 1998 Sep; 334 ( Pt 2)(Pt 2):457-61. PubMed ID: 9716505
[TBL] [Abstract][Full Text] [Related]
32. Antiproliferative effect of 1alpha,25-dihydroxyvitamin D3 in human prostate cancer cell line LNCaP involves reduction of cyclin-dependent kinase 2 activity and persistent G1 accumulation.
Zhuang SH; Burnstein KL
Endocrinology; 1998 Mar; 139(3):1197-207. PubMed ID: 9492054
[TBL] [Abstract][Full Text] [Related]
33. 1,25(OH)2Vitamin D3 induces elevated expression of the cell cycle inhibitor p18 in a squamous cell carcinoma cell line of the head and neck.
Gedlicka C; Hager G; Weissenböck M; Gedlicka W; Knerer B; Kornfehl J; Formanek M
J Oral Pathol Med; 2006 Sep; 35(8):472-8. PubMed ID: 16918598
[TBL] [Abstract][Full Text] [Related]
34. Insulin-like growth factor binding protein-5 interacts with the vitamin D receptor and modulates the vitamin D response in osteoblasts.
Schedlich LJ; Muthukaruppan A; O'Han MK; Baxter RC
Mol Endocrinol; 2007 Oct; 21(10):2378-90. PubMed ID: 17595320
[TBL] [Abstract][Full Text] [Related]
35. Two novel 14-Epi-analogues of 1,25-dihydroxyvitamin D3 inhibit the growth of human breast cancer cells in vitro and in vivo.
Verlinden L; Verstuyf A; Van Camp M; Marcelis S; Sabbe K; Zhao XY; De Clercq P; Vandewalle M; Bouillon R
Cancer Res; 2000 May; 60(10):2673-9. PubMed ID: 10825140
[TBL] [Abstract][Full Text] [Related]
36. Differential regulation of vitamin D responsive elements in normal and transformed keratinocytes.
Xie Z; Bikle DD
J Invest Dermatol; 1998 May; 110(5):730-3. PubMed ID: 9579536
[TBL] [Abstract][Full Text] [Related]
37. FMS (CSF-1 receptor) prolongs cell cycle and promotes retinoic acid-induced hypophosphorylation of retinoblastoma protein, G1 arrest, and cell differentiation.
Yen A; Sturgill R; Varvayanis S; Chern R
Exp Cell Res; 1996 Nov; 229(1):111-25. PubMed ID: 8940255
[TBL] [Abstract][Full Text] [Related]
38. Cell kinetic characterization of growth arrest in cultured human keratinocytes.
van Ruissen F; van Erp PE; de Jongh GJ; Boezeman JB; van de Kerkhof PC; Schalkwijk J
J Cell Sci; 1994 Aug; 107 ( Pt 8)():2219-28. PubMed ID: 7983181
[TBL] [Abstract][Full Text] [Related]
39. All-trans retinoic acid blocks the antiproliferative prodifferentiating actions of 1,25-dihydroxyvitamin D3 in normal human keratinocytes.
Gibson DF; Bikle DD; Harris J
J Cell Physiol; 1998 Jan; 174(1):1-8. PubMed ID: 9397150
[TBL] [Abstract][Full Text] [Related]
40. 1,25 dihydroxyvitamin D3 enhances the calcium response of keratinocytes.
Ratnam AV; Bikle DD; Cho JK
J Cell Physiol; 1999 Feb; 178(2):188-96. PubMed ID: 10048583
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]